Lovenox Patent Could Be Reissued In Mid-2005, Sanofi-Aventis Says

Patent & Trademark Office allows Sanofi-Aventis’ reissuance application after twice rejecting the request. The company says reissuance of the ’618 patent, which expires in 2012, will bolster its position in litigation against enoxaparin ANDA filers.